Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America

Please note that due to a system merger our fulfilment system will be down beginning September 22nd with an anticipated date to begin shipping orders October 10th. We would like to apologize for any inconvenience by offering you a special 20% discount on select products. Please use Promotional Code 12760. Click here for promotion details.

$99.00

In Stock

Major strides have been made in the treatment and understanding of Myelodysplasia.  The United States Food and Drug Administration (FDA) has approved three new drugs for the treatment of MDS; new disease genes have been discovered; major insights have been made into the biology of the disorder; and animal models of MDS have been developed.  The articles in this issue illustrate the rapid progress in MDS research, from molecular pathophysiology to improved therapies.  Insights into the biology of MDS, the development of model systems to study MDS, and the application of new technologies with unprecedented power to interrogate the cancer genome promise to increase the rate of discovery, transforming our understanding of MDS and leading to improvements in the treatment this disease.

View other titles in the “ The Clinics: Internal Medicine” Series

View all Oncology titles

Author Information

    By Benjamin L. Ebert, MD, PhD

Customer Reviews

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America
  • Hardcover
  • Reference
  • Imprint: Saunders
  • ISBN: 978-1-4377-2203-1
  • Copyright: 2010